Asia Pacific Veterinary Endocrinology Market Size, Share & Trends Analysis Report By Route of Administration (Oral and Other routes), By Animal type (Dogs, Cats, and Other Animals), By Application, By Country and Growth Forecast, 2024 - 2031

Analysis of Market Size & Trends

The Asia Pacific Veterinary Endocrinology Market would witness market growth of 7.2% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Veterinary Endocrinology Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $33,637.3 Thousands by 2031. The Japan market is showcasing a CAGR of 6.5% during (2024 - 2031). Additionally, The India market would register a CAGR of 7.8% during (2024 - 2031).

The veterinary endocrinology market refers to the sector within veterinary medicine focused on diagnosing, treating, and managing hormonal disorders and conditions in animals. This market includes pharmaceuticals, diagnostic tools.

Additionally, the applications of veterinary endocrinology are broad and diverse, encompassing various aspects of animal health and welfare across different species. Veterinary endocrinologists play a crucial role in diagnosing and managing diabetes mellitus in animals.

As India’s livestock sector expands to meet the growing demand for meat, milk, and other animal products, there is a corresponding increase in the prevalence of endocrine disorders among livestock species. Conditions such as metabolic disorders, reproductive hormone imbalances, and thyroid dysfunction affect the health and productivity of animals. According to the National Investment Promotion & Facilitation Agency, India's extensive livestock and poultry resources are crucial in enhancing the socioeconomic conditions of rural populations.

Free Valuable Insights: The Global Veterinary Endocrinology Market is Predict to reach USD 482.2 Million by 2031, at a CAGR of 6.6%

Based on Route of Administration, the market is segmented into Oral and Other routes. Based on Animal type, the market is segmented into Dogs, Cats, and Other Animals. Based on Application, the market is segmented into Pancreatic Disorders, and Other Disorders. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Dechra Pharmaceuticals PLC (EQT AB)
• Elanco Animal Health Incorporated
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Zoetis, Inc.
• LLOYD, Inc.
• Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
• Mars, Inc. (Antech Diagnostics, Inc)

Asia Pacific Veterinary Endocrinology Market Report Segmentation

By Route of Administration

• Oral and
• Other routes

By Animal Type

• Dogs,
• Cats, and
• Other Animals

By Application

• Pancreatic Disorders, and
• Other Disorders

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific